MorrisSchambelanMD
Endocrinology • San Francisco, CADiabetes, Lipid Metabolism
Professor, Internal Medicine, UCSF School of Medicine
Are you Dr. Schambelan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Avenue
Bldg 30 Rm 3501k
San Francisco, CA 94110Phone+1 415-206-4615Fax+1 415-476-4918
Summary
- Dr. Morris Schambelan, MD is an endocrinologist in San Francisco, California. He is currently licensed to practice medicine in California and Pennsylvania. He is a Professor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1968 - 1971
Zuckerberg San Francisco General Hospital and Trauma CenterInternship, Transitional Year, 1962 - 1963
Perelman School of Medicine at the University of PennsylvaniaClass of 1962
Certifications & Licensure
CA State Medical License 1965 - 2025
PA State Medical License 1967 - 1974- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1982
Clinical Trials
- Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine Start of enrollment: 2007 Apr 01
- Effects of Creatine and Resistance Exercise Training in People With HIV Infection Start of enrollment: 2001 Aug 01
- Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 713 citationsSarcopenia With Limited Mobility: An International ConsensusJohn E. Morley, Angela Marie Abbatecola, Josep M. Argilés, Vickie E. Baracos, Juergen M. Bauer
Journal of the American Medical Directors Association. 2011-07-01 - 42 citationsInsulin Resistance in Non-Obese Subjects Is Associated with Activation of the JNK Pathway and Impaired Insulin Signaling in Skeletal MuscleUmesh Masharani, Betty A. Maddux, Xiaojuan Li, Giorgos K. Sakkas, Kathleen Mulligan
Plos One. 2011-05-11 - 69 citationsEffects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.Jean-Marc Schwarz, Kathleen Mulligan, Jeongae Lee, Joan C. Lo, Michael Wen
The Journal of Clinical Endocrinology and Metabolism. 2002-02-01
Press Mentions
Too Little Fat Can Be as Bad as Too MuchJuly 6th, 2004
